LAS VEGAS - Oct. 12, 2004 – Tom Lehman has been recently named the Crestor Charity Challenge winner for his first-place standing entering the final round of the Michelin Championship at Las Vegas.

The Crestor Charity Challenge is a season-long weekly competition that recognizes the tournament leader entering the final round at most PGA Tour events throughout the year. Through this first-of-its kind program, AstraZeneca and its Crestor product will donate approximately $3 million a year to designated health care and PGA Tour charities. At each of the selected tournaments, a $100,000 contribution will be made.

For Lehman's performance, AstraZeneca, on behalf of its Crestor product and the Michelin Championship at Las Vegas, will donate $50,000 to the Las Vegas Founders, who will select a local health care charity at the conclusion of the tournament. An additional $50,000 will be donated to the health care charity of Lehman's choice.

"We are very excited to have the CRESTOR(R) Charity Challenge as part of this weekend's Michelin Championship," said Gary Frey, Las Vegas Founders President. "This is a very beneficial program and the monies will help assist a local charity. We look forward to choosing a worthy charity as the recipient."

The Las Vegas Founders is a non-profit organization whose goal for the city of Las Vegas is to host championship golf tournaments and make a positive impact on the community through charitable giving. The Las Vegas Founders have hosted the PGA Tour and Champions Tour, along with numerous Junior Golf and Collegiate tournaments in Las Vegas. Through PGA Tour events, the Las Vegas Founders have donated more than $10 million to the Las Vegas community.

The Crestor Charity Challenge is the centerpiece of a multi-year PGA Tour partnership with AstraZeneca on behalf of its cholesterol-lowering medication, Crestor. "Giving back is at the heart of the PGA TOUR and AstraZeneca is pleased to be able to support this by offering health education and recognizing local communities through the Crestor Charity Challenge," said Tony Zook, senior vice president, commercial operations, AstraZeneca U.S. "The Crestor Charity Challenge will not only add an exciting new twist to the PGA Tour, it will also help the tour reach its milestone of $1 billion in charitable donations within the next few years."

Crestor Charity Challenge winners will be recognized during the network or cable telecast of each tournament. In addition, AstraZeneca and Crestor will sponsor the PGA TOUR year-end charity special, which is scheduled to air December 19 on ABC.

The PGA TOUR partnership also includes the Crestor Charity Challenge Pavilion, an on-site component at select tournaments featuring interactive exhibits designed to provide health and cholesterol awareness, educational activities, health screenings/assessments, and golf tips by teaching pros for fans.

Fans can log on to http://www.crestor.pgatour.com to take part in weekly contests, read about past Crestor Charity Challenge winners, and learn more about Crestor. Crestor also will be the official sponsor of Tour Fantasy Golf at www.gatour.com/fantasy.